Linked Life Data

16901062

Source:http://linkedlifedata.com/resource/pubmed/id/16901062

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16901062rdf:typepubmed:Citationlld:pubmed
pubmed-article:16901062lifeskim:mentionsumls-concept:C0032961lld:lifeskim
pubmed-article:16901062lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:16901062lifeskim:mentionsumls-concept:C0000768lld:lifeskim
pubmed-article:16901062lifeskim:mentionsumls-concept:C0022709lld:lifeskim
pubmed-article:16901062lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:16901062lifeskim:mentionsumls-concept:C0243077lld:lifeskim
pubmed-article:16901062lifeskim:mentionsumls-concept:C1524063lld:lifeskim
pubmed-article:16901062pubmed:issue29lld:pubmed
pubmed-article:16901062pubmed:dateCreated2006-8-11lld:pubmed
pubmed-article:16901062pubmed:abstractTextRecently, an important study was published concerning the possible teratogenic effects of angiotensin converting enzyme (ACE) inhibitors. Non-diabetic women who had used an ACE inhibitor during the first trimester of pregnancy had a significantly greater chance of giving birth to an infant with congenital malformations than women who had used no or other antihypertensive agents. The excess risk remained even after adjusting for several potential confounders. The results indicate that ACE inhibitors should not be prescribed to women who are likely to become pregnant during the course of treatment.lld:pubmed
pubmed-article:16901062pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16901062pubmed:languagedutlld:pubmed
pubmed-article:16901062pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16901062pubmed:citationSubsetIMlld:pubmed
pubmed-article:16901062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16901062pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16901062pubmed:statusMEDLINElld:pubmed
pubmed-article:16901062pubmed:monthJullld:pubmed
pubmed-article:16901062pubmed:issn0028-2162lld:pubmed
pubmed-article:16901062pubmed:authorpubmed-author:de LeeuwP WPWlld:pubmed
pubmed-article:16901062pubmed:issnTypePrintlld:pubmed
pubmed-article:16901062pubmed:day22lld:pubmed
pubmed-article:16901062pubmed:volume150lld:pubmed
pubmed-article:16901062pubmed:ownerNLMlld:pubmed
pubmed-article:16901062pubmed:authorsCompleteYlld:pubmed
pubmed-article:16901062pubmed:pagination1605-7lld:pubmed
pubmed-article:16901062pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16901062pubmed:meshHeadingpubmed-meshheading:16901062...lld:pubmed
pubmed-article:16901062pubmed:meshHeadingpubmed-meshheading:16901062...lld:pubmed
pubmed-article:16901062pubmed:meshHeadingpubmed-meshheading:16901062...lld:pubmed
pubmed-article:16901062pubmed:meshHeadingpubmed-meshheading:16901062...lld:pubmed
pubmed-article:16901062pubmed:meshHeadingpubmed-meshheading:16901062...lld:pubmed
pubmed-article:16901062pubmed:meshHeadingpubmed-meshheading:16901062...lld:pubmed
pubmed-article:16901062pubmed:meshHeadingpubmed-meshheading:16901062...lld:pubmed
pubmed-article:16901062pubmed:meshHeadingpubmed-meshheading:16901062...lld:pubmed
pubmed-article:16901062pubmed:meshHeadingpubmed-meshheading:16901062...lld:pubmed
pubmed-article:16901062pubmed:year2006lld:pubmed
pubmed-article:16901062pubmed:articleTitle[The use of angiotensin converting enzyme (ACE) inhibitors during pregnancy clearly increases the risk of congenital malformations].lld:pubmed
pubmed-article:16901062pubmed:affiliationAcademisch Ziekenhuis Maastricht, afd. Interne Geneeskunde, Postbus 5800, 6202 AZ Maastricht. p.deleeuw@intmed.unimaas.nllld:pubmed
pubmed-article:16901062pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16901062pubmed:publicationTypeEnglish Abstractlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16901062lld:pubmed